nicardipine has been researched along with propranolol in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (28.99) | 18.7374 |
1990's | 27 (39.13) | 18.2507 |
2000's | 11 (15.94) | 29.6817 |
2010's | 11 (15.94) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coassolo, P; Lavé, T; Schneider, G | 1 |
Topliss, JG; Yoshida, F | 1 |
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
Jolivette, LJ; Ward, KW | 1 |
Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Artursson, P; Mateus, A; Matsson, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kimura, H; Kusaba, T; Nagasawa, K; Otsuka, T; Sakata, T; Tada, Y; Tsuda, Y | 1 |
Kawasaki, H | 1 |
Panarace, G; Pedrinelli, R; Salvetti, A | 1 |
Champion, D; Ekelund, LG; Josselson, J; Korc, M; Pool, JL; Stein, GH; Weir, MR; Wolbach, RA | 1 |
Pedrinelli, R; Salvetti, A | 1 |
Panarace, G; Pedrinelli, R; Salvetti, A; Spessot, M; Taddei, S | 1 |
David, D; Guerret, M; Kahn, JC; Marchand, X; Rocha, P | 1 |
Hanet, C; Pouleur, H; Rousseau, MF; van Eyll, C | 1 |
Featherston, W; Gonzalez, DG; Kaplan, NM; Lugo, C; Ralakis, J; Ram, CV | 1 |
Ogihara, M; Sunaga, K | 1 |
Dupont, AG; Massart, DL; Musch, G; Schoors, DF; Vercruysse, I | 1 |
Beleslin, DB; Jovanović-Micić, D; Samardzić, R | 1 |
Akahane, K; Chiba, S; Furukawa, Y; Ogiwara, Y | 1 |
Azzollini, F; Cereda, A; Pelosi, G; Picca, M | 1 |
Barone, EJ; Berl, T; Detwiler, J; Lessem, JN; Lewin, AT; Lubash, GD; Margolis, R; McGowan, RL; Ram, CV; Vlachakis, N | 1 |
Dow, RJ; Gough, KJ; Laing, EM; Macdonald, FC; Maclean, D; McDevitt, DG; Mitchell, ET | 1 |
Brunner, F; Müller, WE | 1 |
Brown, RD; Cong, Z; Taylor, P | 1 |
Hanet, C; Harlow, BJ; Pouleur, H; Rousseau, MF | 1 |
Abe, H; Ashida, T; Deguchi, F; Imanishi, M; Kawamura, M; Kawano, Y; Kimura, G; Kojima, S; Yoshida, K; Yoshimi, H | 1 |
Naukkarinen, VA | 1 |
Ikeda, J; Karasawa, A; Kubo, K; Nakamizo, N; Oka, T; Yamada, K | 1 |
Bjerle, P; Danielsson, A; Ek, B; Steen, L; Suhr, O | 1 |
Karppinen, K; Naukkarinen, VA; Sarna, S | 1 |
Endou, K; Sato, T; Yamamoto, H | 1 |
McCredie, M; McGill, D; McKenzie, W | 1 |
Douglas-Jones, AP; Havard, CW; Nievel, JG | 1 |
Hanet, C; Pardonge-Lavenne, E; Pouleur, H; Rousseau, MF; Van den Berghe, G; Van Hoof, F | 1 |
Baron, B; David, D; Kahn, JC; Pathe, M; Rocha, P; Zannier, D | 1 |
Henry, PD | 1 |
Brasseur, LA; Charlier, AA; Etienne, J; Pouleur, H; Rousseau, MF; Van Eyll, C; Van Mechelen, H | 1 |
Deguchi, T; Hara, T; Hattori, O; Kato, Y; Saijyo, T; Suzuki, K; Tanaka, H | 1 |
Asakuma, S; Iwasaki, T; Ohyanagi, M | 1 |
Dupont, AG; Massart, DL; Schoors, DF; Vercruysse, I | 1 |
Belpaire, FM; Dupont, AG; Massart, DL; Vercruysse, I; Vermeulen, AM | 1 |
Cabrera-Valdivia, F; Garcia-Ruiz, PJ; Jiménez-Jiménez, FJ | 1 |
Drieu la Rochelle, CD; Grosset, A; O'Connor, SE | 1 |
Belpaire, F; Dupont, AG; Massart, DL; Vercruysse, I; Wynant, P | 1 |
Arriaga-Gracia, J; González-García, CA; Sánchez-Garcia, JL | 1 |
Dupont, AG; Massart, DL; Vercruysse, I | 1 |
Akaike, N; Kobayashi, T; Miyake, N; Nishioka, K; Omura, T | 1 |
Fyhrquist, F; Metsärinne, K; Saijonmaa, O | 1 |
Kawanishi, T; Nakamura, R; Nishimaru, K; Sekine, T; Shigenobu, K; Tanaka, H; Yamagaki, K | 1 |
Gan, Q; Knuepfer, MM; Mueller, PJ | 1 |
Bayguinov, O; Sanders, KM | 1 |
Kotegawa, T; Matsukubo, S; Nakamura, K; Nakano, S; Nakatsuka, K; Tsutsumi, K; Yatsuka, YI | 1 |
Bagatin, J; Polić, S; Rakić, D; Rumboldt, Z | 1 |
Akiyama, Y; Nozawa, H; Sunaga, S; Tsurita, G | 1 |
Broekelmann, TJ; Halabi, CM; Knutsen, RH; Kozel, BA; Mecham, RP; Ye, L | 1 |
2 review(s) available for nicardipine and propranolol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Atherosclerosis, calcium, and calcium antagonists.
Topics: Animals; Aorta; Arteries; Arteriosclerosis; Calcinosis; Calcium; Calcium Channel Blockers; Cell Survival; Cholesterol, Dietary; Cinnarizine; Diltiazem; Flunarizine; Humans; Membrane Lipids; Muscle, Smooth, Vascular; Nicardipine; Nifedipine; Propranolol; Rabbits; Verapamil | 1985 |
17 trial(s) available for nicardipine and propranolol
Article | Year |
---|---|
Calcium entry blockade and adrenergic vascular reactivity in hypertensives: differences between nicardipine and diltiazem.
Topics: Adrenergic alpha-Antagonists; Adult; Biological Transport; Blood Vessels; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Nicardipine; Norepinephrine; Propranolol; Vasoconstriction; Vasodilation | 1991 |
Nicardipine as antihypertensive monotherapy: positive effects on quality of life.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Nicardipine; Propranolol; Quality of Life; Surveys and Questionnaires; Time Factors | 1991 |
Nicardipine and propranolol in the treatment of hypertension: similar antihypertensive but dissimilar hemodynamic actions.
Topics: Antihypertensive Agents; Exercise Test; Hemodynamics; Humans; Hypertension; Middle Aged; Nicardipine; Propranolol; Rest; Time Factors | 1990 |
Influence of nicardipine on the pharmacokinetics and pharmacodynamics of propranolol in healthy volunteers.
Topics: Adult; Biological Availability; Blood Pressure; Drug Interactions; Female; Humans; Male; Nicardipine; Propranolol; Pulse | 1990 |
Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris.
Topics: Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Exercise Test; Female; Humans; Male; Nicardipine; Nifedipine; Nitroglycerin; Propranolol; Single-Blind Method; Verapamil | 1989 |
Nicardipine and propranolol in the treatment of essential hypertension.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Nicardipine; Propranolol; Random Allocation | 1989 |
Comparison of the efficacy and acceptability of nicardipine and propranolol, alone and in combination, in mild to moderate hypertension.
Topics: Adult; Aged; Blood Chemical Analysis; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nicardipine; Propranolol; Random Allocation | 1989 |
Effects of long-term combined dosing with nicardipine and propranolol on coronary hemodynamics, myocardial metabolism, and exercise tolerance in patients with angina pectoris: comparison with monotherapy.
Topics: Adult; Aged; Angina Pectoris; Cardiac Pacing, Artificial; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Hemodynamics; Humans; Lactates; Lactic Acid; Male; Middle Aged; Myocardium; Nicardipine; Oxygen Consumption; Propranolol; Random Allocation | 1988 |
Serum lipid changes in patients with mild to moderate essential hypertension taking nicardipine and propranolol.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Nicardipine; Propranolol | 1988 |
Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Electrocardiography; Female; Humans; Hypertension; Middle Aged; Nicardipine; Physical Exertion; Propranolol; Rest | 1987 |
Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension.
Topics: Adult; Blood Pressure; Body Weight; Cholesterol; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Lipids; Lipoproteins; Middle Aged; Nicardipine; Propranolol; Random Allocation; Triglycerides | 1987 |
Comparison of nicardipine and propranolol for chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Dyspnea; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Nicardipine; Nifedipine; Propranolol; Random Allocation | 1986 |
Comparison of concomitant nicardipine hydrochloride and propranolol with propranolol alone in patients with essential hypertension.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Hypertension; Male; Middle Aged; Nicardipine; Propranolol | 1987 |
Nicardipine versus propranolol in essential tumor.
Topics: Adult; Aged; Cross-Over Studies; Female; Humans; Male; Middle Aged; Nicardipine; Propranolol; Tremor | 1994 |
Nicardipine or propranolol combined with hydrochlorothiazide in patients with essential hypertension.
Topics: Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nicardipine; Propranolol | 1993 |
Short-term effects of nicardipine and propranolol on ocular and systemic hemodynamics in healthy Japanese subjects.
Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Double-Blind Method; Hemodynamics; Humans; Intraocular Pressure; Male; Nicardipine; Propranolol | 1998 |
Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
Topics: Adult; Aged; Antihypertensive Agents; Chlorthalidone; Croatia; Echocardiography; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Middle Aged; Nicardipine; Organ Size; Propranolol; Prospective Studies; Treatment Outcome; Ventricular Function, Left | 2002 |
50 other study(ies) available for nicardipine and propranolol
Article | Year |
---|---|
Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques.
Topics: Animals; Biological Availability; Dogs; Humans; Least-Squares Analysis; Liver; Multivariate Analysis; Neural Networks, Computer; Pharmacokinetics; Rats | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Case report: nifedipine-rifampicin interaction attenuates the effect on blood pressure in a patient with essential hypertension.
Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Drug Interactions; Ethambutol; Female; Humans; Hypertension; Isoniazid; Nicardipine; Nifedipine; Propranolol; Quinazolines; Rifampin | 1992 |
Effects of chronic administration of antihypertensive drugs on vasodilation mediated by calcitonin gene-related peptide-containing vasodilator nerves in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcitonin Gene-Related Peptide; Captopril; Electric Stimulation; In Vitro Techniques; Male; Methoxamine; Nicardipine; Peripheral Nerves; Propranolol; Rats; Rats, Inbred SHR; Splanchnic Circulation; Tetrodotoxin; Vasodilation | 1992 |
Heterogeneous interference of nicardipine, verapamil, and diltiazem with forearm arteriolar responsiveness to adrenergic stimulation in hypertensive patients.
Topics: Arterioles; Diltiazem; Female; Forearm; Humans; Hypertension; Lower Body Negative Pressure; Male; Nicardipine; Norepinephrine; Propranolol; Regional Blood Flow; Vasoconstriction; Vasodilation; Verapamil | 1991 |
Calcium entry blockade and agonist-mediated forearm vasoconstriction in hypertensive patients. Difference between nicardipine and verapamil.
Topics: Angiotensin II; Forearm; Humans; Hypertension; Lower Body Negative Pressure; Nicardipine; Phentolamine; Propranolol; Vasoconstriction; Verapamil | 1991 |
Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment.
Topics: Administration, Oral; Adult; Catheterization, Swan-Ganz; Coronary Disease; Drug Interactions; Hemodynamics; Humans; Infusions, Intravenous; Nicardipine; Propranolol | 1990 |
Effects of nicardipine on regional diastolic left ventricular function in patients with angina pectoris.
Topics: Angina Pectoris; Cardiac Output; Cineangiography; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Contraction; Nicardipine; Premedication; Propranolol | 1990 |
Effects of calcium channel blockers and hydralazine on plasma glucose levels in streptozotocin-induced diabetic rats in vivo.
Topics: Animals; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Catecholamines; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hexamethonium Compounds; Hydralazine; Male; Nicardipine; Nifedipine; Phentolamine; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Starvation | 1990 |
Nature of hypo- and hyperthermia induced by the calcium antagonist nicardipine.
Topics: Animals; Body Temperature Regulation; Cats; Fever; Hypothermia; Injections, Intraventricular; Ion Channels; Nicardipine; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Respiration; Yohimbine | 1987 |
Different antagonism of the positive chronotropic and inotropic responses of the isolated, blood-perfused dog atrium to Bay k 8644 by nicardipine and verapamil.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Atrial Function; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Heart Atria; Heart Rate; Myocardial Contraction; Nicardipine; Propranolol; Verapamil | 1988 |
The stereoselectivity of the 'single drug binding site' of human alpha 1-acid glycoprotein (orosomucoid).
Topics: Binding Sites; Dialysis; Humans; Nicardipine; Orosomucoid; Propranolol; Protein Binding; Stereoisomerism; Thermodynamics | 1987 |
Actions of membrane-active drugs on agonist occupation and functional state of nicotinic acetylcholine receptors.
Topics: Calcium Channel Blockers; Carbachol; Cell Line; Cell Membrane Permeability; Fluorescent Dyes; Nicardipine; Propranolol; Receptors, Nicotinic | 1985 |
Antihypertensive drugs and sodium restriction. Analysis of their interaction based on pressure-natriuresis relationship.
Topics: Antihypertensive Agents; Blood Pressure; Captopril; Diet, Sodium-Restricted; Female; Humans; Hypertension; Male; Middle Aged; Natriuresis; Nicardipine; Propranolol | 1988 |
Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in conscious, renal-hypertensive dogs.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chemical Phenomena; Chemistry; Dogs; Female; Heart Rate; Hypertension, Renal; Male; Nicardipine; Nifedipine; Nitrendipine; Propranolol | 1988 |
Comparison of the effects of calcium channel blockers and antiarrhythmic drugs on digitalis-induced oscillatory afterpotentials on canine Purkinje fiber.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Digitalis; Diltiazem; Dogs; Electric Stimulation; Female; Heart Conduction System; Male; Mexiletine; Nicardipine; Nifedipine; Nitrendipine; Plants, Medicinal; Plants, Toxic; Procainamide; Propranolol; Purkinje Fibers; Verapamil | 1987 |
Changes in myocardial metabolism during therapy in patients with chronic stable angina: a comparison of long-term dosing with propranolol and nicardipine.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Pacing, Artificial; Chronic Disease; Exercise Test; Female; Heart Rate; Humans; Lactates; Male; Middle Aged; Myocardium; Nicardipine; Nifedipine; Propranolol; Tachycardia; Time Factors | 1986 |
Acute hemodynamic effects of intravenous nicardipine in patients treated chronically with propranolol for coronary artery disease.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Coronary Disease; Drug Therapy, Combination; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Nicardipine; Propranolol; Vascular Resistance | 1987 |
Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease.
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Drug Therapy, Combination; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Nicardipine; Nifedipine; Propranolol | 1984 |
Effect of the new calcium antagonist (+/-)-(R*)-3-[(R*)-1-benzyl-3- piperidyl] methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5- pyridinedicarboxylate hydrochloride (KW-3049) on cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiomegaly; DNA; Heart Rate; Hypertension; Male; Myocardium; Nicardipine; Nifedipine; Organ Size; Propranolol; Rats; Rats, Inbred SHR; Renin; RNA | 1993 |
The effects of antianginal drugs on energy expenditure during exercise in normal subjects.
Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Energy Metabolism; Ethanolamines; Exercise; Humans; Isosorbide Dinitrate; Male; Metoprolol; Middle Aged; Nicardipine; Propranolol | 1995 |
Influences of the calcium antagonists nicardipine and nifedipine, and the calcium agonist BAY-K-8644, on the pharmacokinetics of propranolol in rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Administration, Oral; Animals; Biological Availability; Calcium Channel Agonists; Calcium Channel Blockers; Drug Interactions; Injections, Intravenous; Male; Nicardipine; Nifedipine; Propranolol; Rats; Rats, Wistar | 1993 |
The effect of different calcium antagonists and a calcium agonist on the metabolism of propranolol by isolated rat hepatocytes.
Topics: Aging; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Drug Interactions; Liver; Male; Nicardipine; Propranolol; Rats; Rats, Wistar; Stereoisomerism | 1994 |
Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog.
Topics: Animals; Atropine; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Dihydropyridines; Dogs; Electrocardiography; Female; Heart Conduction System; Heart Rate; Hemodynamics; Male; Myocardial Contraction; Nicardipine; Oxygen Consumption; Propranolol; Vascular Resistance; Vasodilation | 1994 |
Enantioselective inhibitory effect of nicardipine on the hepatic clearance of propranolol in man.
Topics: Adult; Blood Pressure; Blood Proteins; Chromatography, High Pressure Liquid; Female; Humans; Liver; Male; Nicardipine; Propranolol; Protein Binding; Sex Characteristics; Stereoisomerism | 1994 |
Increase in plasma propranolol caused by nicardipine is dependent on the delivery rate of propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Delayed-Action Preparations; Drug Interactions; Female; Humans; Male; Nicardipine; Propranolol | 1995 |
Ca(2+)-antagonistic action of bevantolol on hypothalamic neurons in vitro: its comparison with those of other beta-adrenoceptor antagonists, a local anesthetic and a Ca(2+)-antagonist.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Calcium Channel Blockers; Hypothalamus, Middle; Lidocaine; Neurons; Nicardipine; Patch-Clamp Techniques; Propanolamines; Propranolol; Rats; Rats, Wistar | 1996 |
Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Ascorbic Acid; Calcium Channel Blockers; Carbazoles; Carvedilol; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Humans; Metoprolol; Nicardipine; Prazosin; Probucol; Propanolamines; Propranolol; Umbilical Veins | 1997 |
Two-dimensional millisecond analysis of intracellular Ca2+ sparks in cardiac myocytes by rapid scanning confocal microscopy: increase in amplitude by isoproterenol.
Topics: Adrenergic beta-Antagonists; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calmodulin-Binding Proteins; Cardiotonic Agents; Colforsin; Heart; Isoproterenol; Microscopy, Confocal; Muscle Proteins; Myocardium; Nicardipine; Propranolol; Rats; Ryanodine; Ryanodine Receptor Calcium Release Channel; Time Factors | 1997 |
Mechanisms of hemodynamic responses to cocaine in conscious rats.
Topics: Adrenergic beta-Antagonists; Animals; Calcium Channels; Calcium Channels, L-Type; Cocaine; Enzyme Inhibitors; Hemodynamics; Male; Metoprolol; NG-Nitroarginine Methyl Ester; Nicardipine; Nitric Oxide; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta | 1998 |
Dissociation between electrical and mechanical responses to nitrergic stimulation in the canine gastric fundus.
Topics: Animals; Arginine; Atropine; Calcium; Cytosol; Dogs; Electric Stimulation; Female; Gastric Fundus; Guanylate Cyclase; In Vitro Techniques; Male; Membrane Potentials; Muscle Relaxation; Muscle, Smooth; Nicardipine; Nitric Oxide; Nitroprusside; Oxadiazoles; Oxyhemoglobins; Phentolamine; Propranolol; Quaternary Ammonium Compounds; Quinoxalines; Stomach; Synaptic Transmission; Time Factors | 1998 |
Ischemic colitis following colonoscopy in an elderly patient on cardiovascular medication.
Topics: Aged, 80 and over; Arrhythmias, Cardiac; Cardiovascular Agents; Colitis, Ischemic; Colonic Neoplasms; Colonic Polyps; Colonoscopy; Digoxin; Drug Therapy, Combination; Female; Humans; Hypertension; Intestinal Mucosa; Nicardipine; Postoperative Complications; Propranolol; Risk Factors; Sigmoid Neoplasms | 2007 |
Chronic antihypertensive treatment improves pulse pressure but not large artery mechanics in a mouse model of congenital vascular stiffness.
Topics: Animals; Antihypertensive Agents; Arteries; Blood Pressure; Elastin; Losartan; Mice; Mice, Inbred C57BL; Nicardipine; Propranolol; Vascular Stiffness; Williams Syndrome | 2015 |